News
Lilly expands India presence with inauguration of Hyderabad site to accelerate global digital innovation: Our Bureau, Mumbai ...
Peethaambaran Kunnathoor, Chennai Monday, August 4, 2025, 08:00 Hrs [IST] ...
RoboGynIndia 2025, in partnership with Vattikuti Foundation, showcases India’s leadership in robotic gynaecologic surgery: Our Bureau, Mumbai Monday, August 4, 2025, 17:30 Hrs [ ...
Repligen inks partnership with Novasign to further advance bioprocessing digitalization: Waltham, Massachusetts Monday, August 4, 2025, 17:00 Hrs [IST] Repligen Corporation, a lif ...
Palisade Bio’s locally-activated, terminal ileum and colon-targeted PDE4 B/D inhibitor, PALI-2108 receives Chinese patent: Carlsbad, California Monday, August 4, 2025, 16:00 Hrs ...
Max Healthcare and Global Health Alliance UK to drive advanced specialised medical training and research: Our Bureau, Bengaluru Monday, August 4, 2025, 15:45 Hrs [IST] Max Healthc ...
CitiusTech, with Maharashtra govt’s Cama & Albless Hospital to renovate Department of Urogynecology to global standards: Our Bureau, Bengaluru Monday, August 4, 2025, 13:45 Hrs ...
Agilent and TIFR, Hyderabad collaborate to advance scientific frontiers in health and metabolism research: Our Bureau, Bengaluru Monday, August 4, 2025, 15:30 Hrs [IST] Agilent Te ...
Profusa signs Letter of Intent for distribution of Lumee Oxygen platform in Spain: Berkeley, California Monday, August 4, 2025, 14:00 Hrs [IST] Profusa, Inc. (Profusa), a commerci ...
Dana-Farber research shows promise for targeted therapies for paediatric gliomas: Boston, Massachusetts Monday, August 4, 2025, 15:00 Hrs [IST] A collaborative study between Dana- ...
Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration: Basel Monday, August 4, 2025, 11:00 Hrs [ ...
Everest Medicines to invest US$ 30.9 million in US-based global biotech company, I-MAB: Shanghai, China Monday, August 4, 2025, 10:00 Hrs [IST] Everest Medicines, a biopharmaceuti ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results